Control of cell proliferation by Polycomb group proteins (PcG) is an important facet of cellular homeostasis and its disruption can promote tumorigenesis. We recently described CBX7 as a novel PcG protein controlling the growth of normal cells. In an attempt to identify a putative role of CBX7 in tumorigenesis, we analysed CBX7 expression in a panel of cancer cell lines and primary tissues. CBX7 was highly expressed in three different prostate cancer cell lines and present at elevated levels in normal prostate. Ablation of CBX7 expression using short hairpin RNAs (shRNA) resulted in upregulation of p16(Ink4a) and p14(Arf) in both LNCaP and PC-3 prostate cell lines. CBX7 knockdown caused an impairment of cell growth that was dependent on the status of the p14(Arf)/p53 and p16(Ink4a)/Rb pathways in both normal and cancer prostate cells. CBX7 overexpression in LNCaP cells resulted in a slight growth advantage in both androgen-dependent and independent conditions. Moreover, CBX7 expression cooperated with c-Myc in rendering LNCaP cells insensitive to growth arrest by androgen receptor inhibition. Together, these data suggest that CBX7 represses p16(Ink4a) and p14(Arf) expression in normal and tumor-derived prostate cells, affecting their growth depending on the status of the p16(Ink4a)/Rb and the p14(Arf)/p53 pathways.
Abate-Shen C., Molecular genetics of prostate cancer, 10.1101/gad.819500
Baylin Stephen B, Herman James G, DNA hypermethylation in tumorigenesis: epigenetics joins genetics, 10.1016/s0168-9525(99)01971-x
Bea S, Cancer Res., 61, 2409 (2001)
Bernard David, Pourtier-Manzanedo Albin, Gil Jesús, Beach David H., Myc confers androgen-independent prostate cancer cell growth, 10.1172/jci200319035
Bracken A. P., EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer, 10.1093/emboj/cdg542
Cao R., Wang L., Wang H., Xia L., Erdjument-Bromage H., Tempst P., Jones R. S., Zhang Y., Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing, 10.1126/science.1076997
Carroll AG, Prostate, 23, 123 (1993)
Chi SG, Clin. Cancer Res., 3, 1889 (1997)
Drayton Sarah, Rowe Janice, Jones Rebecca, Vatcheva Radost, Cuthbert-Heavens Darren, Marshall John, Fried Mike, Peters Gordon, Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes, 10.1016/s1535-6108(03)00242-3
Feldman Brian J., Feldman David, The development of androgen-independent prostate cancer, 10.1038/35094009
Francis Nicole J., Kingston Robert E., Mechanisms of transcriptional memory, 10.1038/35073039
Futreal P. Andrew, Coin Lachlan, Marshall Mhairi, Down Thomas, Hubbard Timothy, Wooster Richard, Rahman Nazneen, Stratton Michael R., A census of human cancer genes, 10.1038/nrc1299
Gil Jesús, Bernard David, Martínez Dolores, Beach David, Polycomb CBX7 has a unifying role in cellular lifespan, 10.1038/ncb1077
Jacobs Jacqueline J.L., van Lohuizen Maarten, Polycomb repression: from cellular memory to cellular proliferation and cancer, 10.1016/s0304-419x(02)00052-5
Kasibhatla Shailaja, Brunner Thomas, Genestier Laurent, Echeverri Fernando, Mahboubi Artin, Green Douglas R, DNA Damaging Agents Induce Expression of Fas Ligand and Subsequent Apoptosis in T Lymphocytes via the Activation of NF-κB and AP-1, 10.1016/s1097-2765(00)80054-4
Kirmizis A, Mol. Cancer Ther., 2, 113 (2003)
Kirmizis A., Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27, 10.1101/gad.1200204
Kleer C. G., Cao Q., Varambally S., Shen R., Ota I., Tomlins S. A., Ghosh D., Sewalt R. G. A. B., Otte A. P., Hayes D. F., Sabel M. S., Livant D., Weiss S. J., Rubin M. A., Chinnaiyan A. M., EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells, 10.1073/pnas.1933744100
Kuzmichev A., Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein, 10.1101/gad.1035902
Lessard Julie, Sauvageau Guy, Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells, 10.1038/nature01572
Lu S, Cancer Res., 57, 4511 (1997)
Lund Anders H, van Lohuizen Maarten, Polycomb complexes and silencing mechanisms, 10.1016/j.ceb.2004.03.010
Raaphorst Frank M., van Kemenade Folkert J., Blokzijl Tjasso, Fieret Elly, Hamer Karien M., Satijn David P.E., Otte Arie P., Meijer Chris J.L.M., Coexpression of BMI-1 and EZH2 Polycomb Group Genes in Reed-Sternberg Cells of Hodgkin’s Disease, 10.1016/s0002-9440(10)64583-x
Satijn D P, Olson D J, van der Vlag J, Hamer K M, Lambrechts C, Masselink H, Gunster M J, Sewalt R G, van Driel R, Otte A P, Interference with the expression of a novel human polycomb protein, hPc2, results in cellular transformation and apoptosis., 10.1128/mcb.17.10.6076
Tokimasa S, Lack of the Polycomb-group gene rae28 causes maturation arrest at the early B-cell developmental stage, 10.1016/s0301-472x(00)00620-2
van Kemenade F. J., Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma, 10.1182/blood.v97.12.3896
Varambally Sooryanarayana, Dhanasekaran Saravana M., Zhou Ming, Barrette Terrence R., Kumar-Sinha Chandan, Sanda Martin G., Ghosh Debashis, Pienta Kenneth J., Sewalt Richard G. A. B., Otte Arie P., Rubin Mark A., Chinnaiyan Arul M., The polycomb group protein EZH2 is involved in progression of prostate cancer, 10.1038/nature01075
Visser Hein P. J., Gunster Marco J., Kluin-Nelemans Hanneke C., Manders Erik M. M., Raaphorst Frank M., Meijer Chris J. L. M., Willemze Roel, Otte Arie P., The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma, 10.1046/j.1365-2141.2001.02641.x
Wang J, Genes Dev., 12, 1769 (1998)
Wang Liangjun, Brown J.Lesley, Cao Ru, Zhang Yi, Kassis Judith A, Jones Richard S, Hierarchical Recruitment of Polycomb Group Silencing Complexes, 10.1016/j.molcel.2004.05.009
Zindy F, Genes Dev., 12, 2424 (1998)
Bibliographic reference
Bernard, D ; Martinez-Leal, JF ; Rizzo, S ; Martinez, D ; Hudson, D ; et. al. CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus. In: Oncogene : including Oncogene Reviews, Vol. 24, no. 36, p. 5543-5551 (2005)